| 000 | 01514 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513230014.0 | ||
| 264 | 0 | _c20010301 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0300-9564 | ||
| 024 | 7 |
_a10.1007/s007020070020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPinter, M M | |
| 245 | 0 | 0 |
_aAn open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease. _h[electronic resource] |
| 260 |
_bJournal of neural transmission (Vienna, Austria : 1996) _c2000 |
||
| 300 |
_a1307-23 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBenzothiazoles |
| 650 | 0 | 4 |
_aDopamine Agonists _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aPramipexole |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aThiazoles _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRutgers, A W | |
| 700 | 1 | _aHebenstreit, E | |
| 773 | 0 |
_tJournal of neural transmission (Vienna, Austria : 1996) _gvol. 107 _gno. 11 _gp. 1307-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s007020070020 _zAvailable from publisher's website |
| 999 |
_c11085002 _d11085002 |
||